Uric acid is an important predictor for hypertensive early atherosclerosis

Advances in Therapy

Volumn 29, Issue 3, 2012, Pages 276-286

  Mutluay, Ruya ^a   Deger, Serpil Muge ^b,c   Bahadir, Eylem ^a   Durmaz, Alim Ozgur ^a   Çitil, Riza ^d   Sindel, Sukru ^b  

^a Sirnak Hospital   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d Sirnak Administrative Province   (Turkey)

Author keywords

Age; Atherosclerosis; Blood pressure; Carotid intima media thickness; Hypertension; Uric acid

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG USE; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERURICEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PROTEIN BLOOD LEVEL; PROTEINURIA; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPERURICEMIA; MALE; MIDDLE AGED; PROTEINURIA; RISK FACTORS; URIC ACID;

EID: 84858699316     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-012-0006-z     Document Type: Article

References (43)

1. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press. 2009;18:308-47.
2. Vasan RS, Larson MG, Leip EP, et al. Impact of highnormal blood pressure on the risk of cardiovascular disease. N Eng J Med. 2001;345:1291-7.
3. Kshirsagar AV, Carpenter M, Bang H, et al. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med. 2006;119:133-41. (Pubitemid 43151479)
4. Zanchetti A, Hennig M, Hollweck R, et al. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation. 2009;120:1084-90.
5. Sehestedt T, Jeppesen J, Hansen TW, et al. Which markers of subclinical organ damage to measure in individuals with high normal blood pressure? J Hypertens. 2009;27:1165-71.
6. Hurst RT, Ng DW, Kendall C, et al. Clinical use of carotid intima-media thickness: review of the literature. J Am Soc Echocardiogr. 2007;20:907-14. (Pubitemid 47016908)
7. So A, Thorens B. Uric acid transport and disease. J Clin Invest. 2010;120:1791-9.
8. Bagnati M, Perugini C, Cau C, et al. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J. 1999;340:143-52. (Pubitemid 29251101)
9. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67:1739-42.
10. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-7.
11. De Luca G, Secco GG, Santagostino M, et al. Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. Nutr Metab Cardiovasc Dis. 2010; [Epub ahead of print].
12. Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131:7-13. (Pubitemid 29310011)
13. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72. (Pubitemid 37430158)
14. Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-91. (Pubitemid 34778969)
15. Tavil Y, Kaya MG, Oktar SO, et al. Uric acid level and its association with carotid intimamedia thickness in patients with hypertension. Atherosclerosis. 2008;197:159-63. (Pubitemid 351273235)
16. Neogi T, Ellison RC, Hunt S, et al. Serum uric acid is associated with carotid plaques: the National Heart, Lung, and Blood Institute Family Heart Study. J Rheumatol. 2009;36:378-84.
17. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000;283:2404-10. (Pubitemid 30257539)
18. Liese AD, Hense HW, Lowel H, et al. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology. 1999;10:391-7. (Pubitemid 29288237)
19. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17:151-83.
20. Zheng L, Sun Z, Li J, et al. Pulse pressure and mean arterial pressure in relation to ischemic stroke among patients with uncontrolled hypertension in rural areas of China. Stroke. 2008;39:1932-7.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
22. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70. (Pubitemid 29135798)
23. Ruilope LM, Garcia-Puig J. Hyperuricemia and renal function. Curr Hypertens Rep. 2001;3:197-202.
24. Bilginer Y, Ozaltin F, Basaran C, et al. Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis. Rheumatol Int. 2008;28:1211-6.
25. Armentano R, Megnien JL, Simon A, et al. Effects of hypertension on viscoelasticity of carotid and femoral arteries in humans. Hypertension. 1995;26:48-54.
26. McEniery CM, Wilkinson IB, Avolio AP. Age, hypertension and arterial function. Clin Exp Pharmacol Physiol. 2007;34:665-71. (Pubitemid 46953116)
27. Haig A. On Uric Acid and Arterial Tension. Br Med J. 1889;1:288-91.
28. Taniguchi Y, Hayashi T, Tsumura K, et al. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey. J Hypertens. 2001;19:1209-15. (Pubitemid 32595276)
29. Grayson PC, Kim SY, LaValley M, et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63:102-10.
30. Nagahama K, Inoue T, Iseki K, et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res. 2004;27:835-41. (Pubitemid 40309449)
31. Mellen PB, Bleyer AJ, Erlinger TP, et al. Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension. 2006;48:1037-42. (Pubitemid 44772705)
32. Mazzali M, Kanbay M, Segal MS, et al. Uric acid and hypertension: cause or effect? Curr Rheumatol Rep. 2010;12:108-17.
33. Kanbay M, Ozkara A, Selcoki Y, et al. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol. 2007;39:1227-33. (Pubitemid 350193621)
34. Mikuls TR, Farrar JT, Bilker WB, et al. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis. 2005;64:267-72. (Pubitemid 40197509)
35. Leite ML. Uric acid and fibrinogen: age-modulated relationships with blood pressure components. J Hum Hypertens. 2011;25:476-83.
36. Riegersperger M, Covic A, Goldsmith D. Allopurinol, uric acid, and oxidative stress in cardiorenal disease. Int Urol Nephrol. 2011;43:441-9.
37. Moriarity JT, Folsom AR, Iribarren C, et al. Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 2000;10:136-43. (Pubitemid 30171270)
38. Choi HK, Ford ES, Li C, et al. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2007;57:109-15.
39. Montalcini T, Gorgone G, Gazzaruso C, et al. Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women. Intern Emerg Med. 2007;2:19-23.
40. Kawamoto R, Tomita H, Oka Y, et al. Association between uric acid and carotid atherosclerosis in elderly persons. Int Med. 2005;44:787-93. (Pubitemid 41263821)
41. Kang DH, Han L, Ouyang X, et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol. 2005;25:425-33. (Pubitemid 41433885)
42. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183-90. (Pubitemid 36706063)
43. Tsukimori K, Yoshitomi T, Morokuma S, et al. Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia. Am J Hypertens. 2008;21:1343-6.